Derivatized porous silicon
Biomaterial comprising derivatized porous silicon is described. Derivatization of the porous silicon has been found to increase its stability. The porous silicon is preferably derivatized by a technique that does not involve oxidation of the silicon, e.g. by hydrosilylation. The derivatized porous silicon is stable to boiling in aerated water for preferably at least two hours. The derivatized porous silicon is preferably at least substantially stable to boiling in aerated basic solutions of aqueous KOH (pH 10) and solutions of 25% EtOH/75% aqueous KOH (pH 10) for one hour. The corrosion rate of the derivatized porous silicon material in simulated human plasma, is a factor of at least two orders of magnitude lower than underivatized porous silicon. The porosity of the derivatized porous silicon is preferably least 5%. Devices comprising the derivatized porous silicon are also described. These include immunoisolation devices, biobattery devices, and optical devices.
1 - 90 . (canceled)
91 . A method of treating an animal or human by:
(a) implanting into the human or animal a sample of porous silicon, and
(b) allowing tissue growth on the surface of the porous silicon, or allowing the porous silicon to corrode;
wherein the porous silicon comprises derivatized porous silicon having a substantially monomolecular layer, the monomolecular layer comprising one or more organic groups that are covalently bonded by hydrosilylation to at least part of the surface of the porous silicon.
92 . A method according to claim 91 wherein the derivatised porous is derivatized mesoporous silicon.
93 . A method according to claim 92 wherein the derivatised porous silicon has a composition and structure such that the corrosion rate of the derivatized mesoporous silicon material in SHP is a factor of at least two orders of magnitude lower than underivatized mesoporous silicon.